Literature DB >> 9190859

Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans.

K Fattinger1, D Verotta, N L Benowitz.   

Abstract

Tolerance is an important determinant of addiction as well as therapeutic and/or toxic effects of drugs. The development of acute tolerance to various effects of nicotine was studied in nine healthy smokers who were abstaining from tobacco. Nicotine was infused rapidly to reach a concentration of about 25 ng/ml, followed by a computer-controlled infusion to maintain that concentration. A novel semiparametric model of nicotine effects and tolerance was developed. Tolerance to various effects of nicotine (increases in heart rate, blood pressure, plasma epinephrine and energy expenditure) occurred within the range of nicotine levels found in smokers. However, the rate of tolerance development varied considerably. The half-lives of tolerance ranged from 3.5 min for the increase in energy expenditure to 70 min for systolic blood pressure. There was no apparent tolerance to the effects on free fatty acid concentrations, which reflects lipolysis. Differences in the pharmacodynamics of tolerance may reflect differences in rate of desensitization of various subtypes of nicotinic receptors and/or differences in mechanisms of tolerance for various nicotinic effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9190859

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

Review 1.  Interchangeability and predictive performance of empirical tolerance models.

Authors:  M Gårdmark; L Brynne; M Hammarlund-Udenaes; M O Karlsson
Journal:  Clin Pharmacokinet       Date:  1999-02       Impact factor: 6.447

2.  Influence of arterial vs. venous sampling site on nicotine tolerance model selection and parameter estimation.

Authors:  Franziska Schaedeli; Maria Pitsiu; Neal L Benowitz; Steven G Gourlay; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-02       Impact factor: 2.745

3.  Risk factor paradox: No prognostic impact of arterial hypertension and smoking in patients with ventricular tachyarrhythmias.

Authors:  Kathrin Weidner; Michael Behnes; Jonas Rusnak; Gabriel Taton; Tobias Schupp; Linda Reiser; Armin Bollow; Thomas Reichelt; Dominik Ellguth; Niko Engelke; Philip Kuche; Jorge Hoppner; Ibrahim El-Battrawy; Siegfried Lang; Christoph A Nienaber; Kambis Mashayekhi; Dennis Ferdinand; Christel Weiß; Martin Borggrefe; Ibrahim Akin
Journal:  Cardiol J       Date:  2018-12-19       Impact factor: 2.737

4.  Self-administered and yoked nicotine produce robust increases in blood pressure and changes in heart rate with modest effects of behavioral contingency in rats.

Authors:  Eric C Donny; Anthony R Caggiula; Maggie Sweitzer; Nadia Chaudhri; Maysa Gharib; Alan F Sved
Journal:  Pharmacol Biochem Behav       Date:  2011-04-29       Impact factor: 3.533

5.  Modelling the cardiovascular effects of ephedrine.

Authors:  Adam M Persky; N Seth Berry; Gary M Pollack; Kim L R Brouwer
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

6.  Nicotine dependence: development, mechanisms, individual differences and links to possible neurophysiological correlates.

Authors:  Ernest Groman; Karl Fagerström
Journal:  Wien Klin Wochenschr       Date:  2003-03-31       Impact factor: 1.704

7.  Modelling acute tolerance to the EEG effect of two benzodiazepines.

Authors:  Harald Ihmsen; Sven Albrecht; Werner Hering; Jürgen Schüttler; Helmut Schwilden
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

8.  Joint Model of Iron and Hepcidin During the Menstrual Cycle in Healthy Women.

Authors:  Adeline Angeli; Fabrice Lainé; Audrey Lavenu; Martine Ropert; Karine Lacut; Valérie Gissot; Sylvie Sacher-Huvelin; Caroline Jezequel; Aline Moignet; Bruno Laviolle; Emmanuelle Comets
Journal:  AAPS J       Date:  2016-02-02       Impact factor: 4.009

9.  Acute and chronic sympathomimetic effects of e-cigarette and tobacco cigarette smoking: role of nicotine and non-nicotine constituents.

Authors:  Sara Arastoo; Kacey P Haptonstall; Yasmine Choroomi; Roya Moheimani; Kevin Nguyen; Elizabeth Tran; Jeffrey Gornbein; Holly R Middlekauff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-19       Impact factor: 5.125

10.  Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers.

Authors:  D A Dempsey; G St Helen; P Jacob; R F Tyndale; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2013-08-09       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.